Trial Profile
Study of ORL-1M (D-mannose) in Patients With CDG-Ib
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs ORL-1M (Primary)
- Indications Congenital disorders
- Focus Therapeutic Use
- Sponsors Orpha Labs
- 04 Oct 2018 Planned End Date changed from 1 Jun 2018 to 1 Jun 2019.
- 04 Oct 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 25 Jan 2018 New trial record